Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
WeVee is a platform that brings Electric Vehicles (EVs) into one place so that potential customers can browse across different models and makes, compare them, get relevant pricing, and configure a leasing plan, with the help of reliable EV experts. The company asserts that its pricing configurator pulls from some of the UK's top lenders such as Lex Autolease, LeasePlan, Arval UK, and ALD Automotive, using Application Programming Interface (API's) to show the best price for each lease configuration. WeVee argues that over 800 vehicles have been ordered on its portal to date. It has also earned £830,000 worth of revenue since launch and garnered 350+ 5-star Trustpilot reviews. WeVee will use the investment for technology development, marketing, contingency purposes, towards paying its tech, leadership, marketing, and operations teams, and upgrades to its IT hardware.
days to go:
Expired
investment:
£1,602,196
Alter Vego (AV) aims to create an extensive range of plant-based, customisable supplements. The company asserts that its production process is sustainable. It starts by creating a vegan protein base blend from ingredients such as pea, hemp, quinoa and brown rice that is ethically sourced and produced. It then develops daily sachets that contain Omega 3, B12, D3, K1, digestive enzymes, and probiotics to complement the base blend. AV argues that the sachets provide 100% of a user's Recommended Dietary Allowance (RDA) over any pre-mixed bulk blend. It aspires to become a contender in the global nutrition sector worth $702 billion. AV will use the investment for manufacturing and marketing its products across the UK.
days to go:
Expired
investment:
£46,455
Brompton's bicycle hire allows people to hire folding bicycles from hiring stations. The hiring stations (docks) are sold to partners. The company have already sold 44 docks to partners. They are looking for investment to prepare the business for international expansion. The funding will used to increase the size of their network by placing more docks in strategic locations. Their service will also be developed with the funds, working on their customer service and developing their skills.
days to go:
Expired
investment:
£380,000
SpaceX is an aerospace manufacturer and space transportation services company founded in 2002 by Elon Musk that aims to reduce space transportation costs and eventually enable the colonisation of Mars. The company has developed several launch vehicles, rocket engines and Autonomous Spaceport Drone Ship (ASDS) landing platforms. Its project, Falcon 9, became the first rocket to accomplish a propulsive vertical landing in December 2015. As of March 2018, SpaceX had over 100 launches on its manifest representing about $12 billion (£9.24 billion) in contract revenue. The company has also ventured into providing satellite internet access by launching its Starlink project. As of 13th June 2020, it has launched 540 Starlink satellites. It will soon launch its Interplanetary Transport System (ITS), Starship, to further inter-planetary travel and colonisation. They will use the investment to grow its projects across various verticals.
days to go:
Expired
investment:
£8,752,000
BioSure HIV Self Test allows for private testing in a time and place convenient to the user. The test is discreetly delivered in the post and once everything is finished all the testing equipment can be thrown away in the bag provided with the usual rubbish.
days to go:
Expired
investment:
£495,459
planarTECH is an engineering company founded in 2014 as a provider of process equipment for the growth and characterisation of graphene and other emerging 2D materials. Its core product line is the planarGROW Chemical Vapor (CVD) system. The company has the ability to deliver scalable production systems that allow lower-cost production of graphene in comparison to other options currently available in the market. Moreover, from 2014 to 2019, the company’s cumulative revenues exceeded £5 million. The company's products have been installed and used by faculties and students at prestigious universities like Stanford University (USA), IIT- Bombay (India), Deakin University (Australia), and many others. From the investment, the company will utilise 45% as working capital, 30% in Capital Expenditures (CAPEX), 15% in R&D and 10% in hiring additional staff.
days to go:
Expired
investment:
£425,061
